Merrimack Pharmaceuticals Priced, Nasdaq: MACK
Uses its Network Biology system to discover and develop cancer treatments.
Industry: Health Care
First Day Return: -13.7%
| IPO Data | |
|---|---|
| IPO Date | 03/28/2012 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $100 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Cambridge, MA, United States |
| Founded | 1993 |
| Employees at IPO | 218 |
| Website www.merrimackpharma.com | |
Merrimack Pharmaceuticals (MACK) Performance
